Placidiol – Cancer Protective

“Introduction
Placidiol is a next-generation, high-potency cannabidiol (CBD) formulation designed with advanced nano-lipid technology to enhance absorption and therapeutic efficacy. Developed to support patients undergoing cancer treatment, Placidiol offers a plant-based approach to managing chemotherapy-induced side effects such as neuropathy, anxiety, inflammation, and sleep disturbances. With its strong neuroprotective profile, Placidiol helps preserve cognitive function and promotes overall brain health, making it an ideal adjunct in oncology care and supportive therapies.

Clinically backed and quality-assured, Placidiol delivers 167mg/mL of cannabinoids, offering a reliable and targeted approach to natural healing through the modulation of the Endocannabinoid System (ECS) and interaction with key neurological and immune pathways.

Composition & Ingredients
Each mL contains:
– Vijaya (Cannabis sativa L.) Leaf Extract – Pure CBD (167mg/mL):
A potent plant-based compound known for its anti-inflammatory, anxiolytic, neuroprotective, and potential anti-cancer effects. CBD acts on multiple receptors including TRPV1 and PPARγ to help regulate inflammation, induce apoptosis in abnormal cells, and reduce tumour proliferation—without harming healthy cells.
– MCT (Medium-Chain Triglyceride) Oil:
A premium carrier oil that enhances the bioavailability of CBD, ensuring faster and more efficient absorption into the bloodstream for optimal therapeutic outcomes.

Available in:
3mL and 15mL tincture bottles
Includes precision titrated droppers for easy and accurate dosing

Therapeutic Benefits
Placidiol is especially suited for individuals undergoing cancer treatment and those managing chronic neurological or inflammatory conditions. Its benefits include:
– Neuroprotection: CBD acts as a negative allosteric modulator of CB1 receptors in the central nervous system, reducing excitotoxicity, preventing neurotransmitter overload, and protecting nerve cells from damage.
– Chemotherapy-Induced Neuropathy Relief: Helps reduce nerve pain and discomfort resulting from cancer treatments, improving quality of life and functional recovery.
– Anxiolytic Effects: Modulates stress response by interacting with CB2 and serotonin-related pathways to promote calmness and emotional stability.
– Sleep Regulation: Supports restful sleep by easing anxiety and reducing inflammation, particularly helpful in cancer patients with sleep disruptions.
– Anti-inflammatory and Immune Modulation: Interacts with CB2 receptors in immune cells to reduce pro-inflammatory cytokines (e.g., TNF-α, IL-6), thus supporting immune system balance and reducing systemic inflammation.
– Potential Anti-cancer Activity: Early studies, including a 2018 publication in Anticancer Research, suggest promising outcomes with CBD, including tumour size reduction and decreased circulating tumour cells in patients with solid tumours.

Placidiol is a plant-powered ally in cancer care—enhancing quality of life, supporting brain function, and offering natural relief when it’s needed most.”